Sparlon Skin Reaction Safety Study Is Unlikely To Erase Need For Black Box
Executive Summary
Labeling for Sparlon for attention deficit/hyperactivity disorder will likely carry a black box warning for severe dermatological reactions even if Cephalon conducts an additional safety study to obtain approval